ProCE Banner Activity

Incorporating Immune Checkpoint Inhibitors Into Treatment For Patients With HCC

Slideset Download
Download this slideset for expert perspectives on current best practices and emerging strategies in immune checkpoint inhibitor therapy for patients with advanced HCC.

Released: November 10, 2019

Expiration: November 08, 2020

No longer available for credit.

Share

Faculty

Anthony El-Khoueiry

Anthony El-Khoueiry, MD

Associate Professor of Medicine
Division of Medical Oncology, Keck School of Medicine
Norris Comprehensive Cancer Center, University of Southern California
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Bristol Myers Squibb

Eisai

Exelixis

Merck Oncology

Faculty Disclosure

Primary Author

Anthony El-Khoueiry, MD

Associate Professor of Medicine
Division of Medical Oncology, Keck School of Medicine
Norris Comprehensive Cancer Center, University of Southern California
Los Angeles, California